Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: A pilot study

International Journal of Geriatric Psychiatry

Volumn 23, Issue 7, 2008, Pages 670-676

  Pelton, Gregory H ^a,b   Harper, Oliver L ^a   Tabert, Matthias H ^a,b   Sackeim, Harold A ^b   Scarmeas, Nikolaos ^b   Roose, Steven P ^a,b   Devanand, D P ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

Author keywords

Aging; Cognitive impairment; Depression; Donepezil; Memory decline; Randomized clinical trial

Indexed keywords

DONEPEZIL; PLACEBO; SERTRALINE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OPEN STUDY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VERBAL MEMORY;

AGED; ANTIDEPRESSIVE AGENTS; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; DEPRESSIVE DISORDER; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PIPERIDINES; SERTRALINE; TREATMENT OUTCOME;

EID: 48249141061     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1958     Document Type: Article

References (33)

1. Alexopoulos GS, Meyers BS, Young RC, et al. 1993. The course of geriatric depression with 'reversible dementia': a controlled study. Am J Psychiatry 150: 1693-1699.
2. Beats BC, Sahakian BJ, Levy R. 1996. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 26: 591-603.
3. Boone KB, Lesser I, Miller B, et al. 1994. Cognitive functioning in a mildly to moderately depressed geriatric sample: relationship to chronological age. J Neuropsychiatry Clin Neurosci 6: 267-272.
4. Burns A, Rossor M, Hecker J, et al. 1999. The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord 10: 237-244.
5. Burt DB, Zembar MJ, Niederehe G. 1995. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 117: 285-305.
6. Butters MA, Bhalla RK, Mulsant BH, et al. 2004. Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship? Am J Geriatr Psychiatry 12: 387-394.
7. Charney DS, Reynolds CF, 3rd, Lewis L, et al. 2003. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry 60: 664-672.
8. Christodoulou C, Melville P, Scherl WF, et al. 2006. Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 245: 127-136.
9. Davis BM, Mohs RC, Greenwald BS, et al. 1985. Clinical studies of the cholinergic deficit in Alzheimer's disease. I. neurochemical and neuroendocrine studies. J Am Geriatr Soc 33: 741-748.
10. Demaerschalk BM, Wingerchuk DM. 2007. Treatment of vascular dementia and vascular cognitive impairment. Neurologist 13: 37-41.
11. Devanand DP, Pelton GH, Marston K, et al. 2003. Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry 18: 123-130.
12. Devanand DP, Sano M, Tang MX, et al. 1996. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 53: 175-182.
13. Doraiswamy PM, Krishnan KR, Anand R, et al. 2002. Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits? Prog Neuropsychopharmacol Biol Psychiatry 26: 705-712.
14. Ferris S, Schneider L, Farmer M, et al. 2007. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in aami). Int J Geriatr Psychiatry 22: 448-455.
15. Gron G, Brandenburg I, Wunderlich AP, Riepe MW. 2006. Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis. Neurobiol Aging 7: 78-87.
16. Hickie I, Scott E, Mitchell P, et al. 1995. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37: 151-160.
17. King DA, Cox C, Lyness JM, et al. 1998. Quantitative and qualitative differences in the verbal learning performance of elderly depressives and healthy controls. J Int Neuropsychol Soc 4: 115-126.
18. Krishnan KR, Hays JC, George LK, Blazer DG. 1998. Six-month outcomes for mri-related vascular depression. Depress Anxiety 8: 142-146.
19. Lyness JM, Conwell Y, King DA, et al. 1995. Age of onset and medical illness in older depressed inpatients. Int Psychogeriatr 7: 63-73.
20. Petersen RC. 2005. Mild cognitive impairment: where are we? Alzheimer Dis Assoc Disord 19: 166-169.
21. Petersen RC, Doody R, Kurz A, et al. 2001. Current concepts in mild cognitive impairment. Arch Neurol 58: 1985-1992.
22. Petersen RC, Thomas RG, Grundman M, et al. 2005. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352: 2379-2388.
23. Rapp MA, Dahlman K, Sano M, et al. 2005. Neuropsychological differences between late-onset and recurrent geriatric major depression. Am J Psychiatry 162: 691-698.
24. Rogers MA, Bradshaw JL, Pantelis C, Phillips JG. 1998. Frontostriatal deficits in unipolar major depression. Brain Res Bull 47: 297-310.
25. Salloway S, Ferris S, Kluger A, et al. 2004. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 63: 651-657.
26. Salloway S, Malloy P, Kohn R, et al. 1996. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 46: 1567-1574.
27. Saykin AJ, Wishart HA, Rabin LA, et al. 2004. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 127: 1574-1583.
28. Schmitt JA, Wingen M, Ramaekers JG, et al. 2006. Serotonin and human cognitive performance. Curr Pharm Des 12: 2473-2486.
29. Tabert MH, Manly JJ, Liu X, et al. 2006. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 63: 916-924.
30. Tariot PN, Solomon PR, Morris JC, et al. 2000. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The galantamine usa-10 study group. Neurology 54: 2269-2276.
31. Taylor WD, Wagner HR, Steffens DC. 2002. Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects. Am J Geriatr Psychiatry 10: 632-635.
32. Wilson RS, Barnes LL, Mendes De Leon CF, et al. 2002. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 59: 364-370.
33. Yaffe K, Blackwell T, Gore R, et al. 1999. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry 56: 425-430.